22-47 Dr. James Mackay, President & CEO, Aristea Therapeutics
- Author
- Moira Gunn
- Published
- Sun 04 Dec 2022
- Episode Link
- https://share.transistor.fm/s/cff1fd66
Too much of a good thing spells trouble - in this case, that would be neutrophils – the white blood cells that act as our immune system’s first line of defense. It's called PPP, or Palmoplantar Pustulosis. Dr. James Mackay is the President & CEO of Aristea Therapeutics.
